
Medline Inc (MDLN) Stock Forecast & Price Target
Medline Inc (MDLN) Analyst Ratings
Bulls say
Medline is a leading healthcare supply chain company with a competitive advantage in the US market, backed by a strong customer base and strategic partnerships with major health systems. With investments in technology and an extensive product portfolio, the company is well-positioned for continued growth and profitability. From a financial standpoint, Medline's 2025 IPO and planned technology-driven strategies show potential for a favorable return for investors within the next 12 months.
Bears say
Medline is poised for strong growth as it leverages its scale, technology-enabled solutions, and broad product offerings to meet the increasing demand for healthcare products. However, near-term challenges such as fire-related inefficiencies, tariffs, and elevated freight costs may moderate profitability. Additionally, the stock's current valuation, based on an equity value multiple of 12 times projected EBITDAR and 18 times projected NOPAT, leaves little room for upside potential.
This aggregate rating is based on analysts' research of Medline Inc and is not a guaranteed prediction by Public.com or investment advice.
Medline Inc (MDLN) Analyst Forecast & Price Prediction
Start investing in Medline Inc (MDLN)
Order type
Buy in
Order amount
Est. shares
0 shares